0000950170-24-019430.txt : 20240223 0000950170-24-019430.hdr.sgml : 20240223 20240223164016 ACCESSION NUMBER: 0000950170-24-019430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reich Samuel J CENTRAL INDEX KEY: 0001394645 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 24672066 MAIL ADDRESS: STREET 1: ACUITY PHARMACEUTICALS INC STREET 2: 3701 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 BUSINESS PHONE: 605-679-6980 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 4 1 ownership.xml 4 X0508 4 2024-02-21 0001833214 SAB Biotherapeutics, Inc. SABS 0001394645 Reich Samuel J 2100 E 54TH STREET NORTH SIOUX FALLS SD 57104 true true false false CEO & EXECUTIVE CHAIRMAN false Employee Stock Option (right to buy) 5.17 2024-02-21 4 A false 434000 0 A 2034-02-21 Common Stock 434000 434000 D Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter. /s/ Samuel J. Reich 2024-02-23